Most important in brief
- Small cell lung cancer often grows faster than NSCLC and often responds well to the first treatment.
- There are two stages: limited and extensive.
- Limited: usually chemo and radiotherapy at the same time, often followed by immunotherapy.
- Extensive: usually chemotherapy with immunotherapy, then immunotherapy alone.
- The brain is checked with MRI or given preventive radiotherapy.
What is small cell lung cancer?
About 15 in 100 lung cancers are small cell. Under the microscope the cells are small and divide quickly. The cancer therefore often grows fast and spreads early, including to the brain. Almost everyone affected has smoked.
The good news: it often responds well to the first treatment. Because it grows fast, treatment usually starts within a few days. Sometimes it makes hormones that, for example, lower the sodium in the blood; this can be treated.
Limited or extensive
Instead of stages I to IV, usually only two stages are told apart here:
- Limited (usually stage I to III): the cancer is confined to one side of the chest and fits in one radiotherapy field. The aim is cure or long-term control.
- Extensive (usually stage IV): the cancer has spread further. The first treatment often works well; after that, treatment is planned line by line.
Which tests matter
| Test | What it is for |
|---|---|
| Pathology reportAt the start | Confirmed small cell lung cancer. |
| CT and PET-CTBefore treatment | Show how far it has spread. |
| Brain MRIBefore treatment | Especially important: this cancer often spreads to the brain. Before treatment and at check-ups. |
| Blood tests, including sodiumBefore treatment | This cancer can make hormones that, for example, lower the sodium in the blood. This can be treated. |
| Biomarker tests, rarely neededAsk about it | Usually not needed in small cell lung cancer. Exception: people who never smoked, or when it developed from EGFR lung cancer. |
Treatment in limited stage
Usually chemo and radiotherapy are given at the same time. Radiotherapy either twice a day for 3 weeks or once a day for 6 to 7 weeks, as early as possible; plus 4 cycles of cisplatin or carboplatin with etoposide.
Surgery is only done for a very small tumour without affected lymph nodes.
| Step | Option | When |
|---|---|---|
| Main treatment | e.g.++or++ | The usual approach in limited stage. Chemo and radiotherapy at the same time, radiotherapy as early as possible. |
Only for a very small tumour without affected lymph nodes. Chemotherapy follows. | ||
For a small tumour without affected lymph nodes, when surgery is not possible; with chemotherapy. | ||
| Afterwards | Immunotherapy after chemoradiotherapye.g. | Up to 2 years, if the cancer has not grown afterwards. In the EU since March 2025. |
Chemotherapye.g.+or+ | After surgery or precise radiotherapy, usually 4 cycles. With affected lymph nodes often radiotherapy as well. | |
After a good response. Either preventive brain radiotherapy or regular MRI checks; weigh up together. | ||
| If it comes back | Treatment as in extensive stage | If it comes back, it is usually treated as in extensive stage. How long it took to come back helps decide whether platinum chemo is possible again. |
| Alongside | Supportive care | For symptoms, from the start. |
Rehabilitation, breathing exercises and stopping smoking | Help recovery and lower the risk of complications. |
Treatment in extensive stage
The first treatment is usually chemotherapy with immunotherapy. After 4 cycles the immunotherapy continues on its own for as long as it works. If the cancer grows again, the next step also depends on when that happens.
| Step | Option | When |
|---|---|---|
| First line | Chemo with immunotherapye.g.++or++or++or++ | The usual start: 4 cycles together, then the immunotherapy alone for as long as it works (maintenance). |
Maintenance with two medicinese.g.+ | After 4 cycles of atezolizumab with carboplatin and etoposide, if the cancer has not grown. In the EU since May 2026. | |
Chemo alonee.g.+or+ | When immunotherapy is not suitable, for example with some autoimmune diseases. 4 to 6 cycles. | |
| Second line | Bispecific antibodye.g. | After platinum chemotherapy. In the EU since May 2026. The first two doses with close monitoring. |
Platinum chemo againe.g.+ | If the cancer only grows again some months after the first chemo ended, often: after more than 3 months. | |
Chemo alonee.g. | After platinum chemotherapy, as an infusion or capsule. | |
| Later | What has not been given yet | For example another chemotherapy. |
Focus on comfort | When more treatment would burden more than help. Decided together. | |
| Alongside | For pain, or for spread to the brain or bones. | |
For some people after a good response to the first treatment, when little cancer is left outside the chest. | ||
After a good response. Either preventive brain radiotherapy or regular MRI checks; weigh up together. | ||
Supportive care | For symptoms, from the start, not only at the end. |
Chemotherapy as the basis
Almost every treatment is built on platinum with etoposide: carboplatin or cisplatin, usually 4 cycles every 3 weeks. If the cancer only returns some months after chemo ended, it can be given again.
Otherwise topotecan or newer medicines are options. In the EU, lurbinectedin is only authorised together with atezolizumab, for maintenance.
How chemotherapy works in practice
- Where
- In the day clinic, as an infusion
- How long
- Usually 4 to 6 cycles, about 3 to 4 months
- Check-ups
- Blood count, kidney and liver values before each cycle
- What to watch for
- Take a fever over 38 °C seriously and report it at once. Avoid crowds and sick people when blood counts are low. Discuss vaccinations beforehand.
Keeping an eye on the brain
Small cell lung cancer often spreads to the brain. Preventive brain radiotherapy (PCI) lowers this risk. The alternative: regular MRI checks, with radiotherapy only if spots appear.
PCI: as an outpatient, usually 10 short sessions over 2 weeks. MRI: about every 3 months in the first year, then less often.
After a good response to the first treatment, in limited and extensive stage. Which suits you better is weighed up together.
Questions for your appointment
Why ask?
It decides whether radiotherapy aimed at cure is an option.
Why ask?
Small cell cancer often grows fast; starting early matters.
Why ask?
The goal decides how much burden makes sense.
Why ask?
It changes how many weeks you need to plan for.
Why ask?
It can lengthen life, but it is not on every list.
Why ask?
Both have pros and cons; your view counts.
Why ask?
Together with chemo it can lengthen life; the lists differ.
Why ask?
After a good response it can delay a relapse.
Why ask?
Many new medicines are being tested for small cell lung cancer.
In My path you can pick questions, add your own and print the list.